1. A filter-drier arrangement for refrigerant circuits with at least one drier arrangement and at least one filter arrangement, wherein at least one short-circuiting path extending through the filter arrangement, said path bypassing the drier arrangement and connecting an inlet connection and an outlet connection of the filter-drier arrangement.
2. The filter-drier arrangement according to claim 1, wherein the drier arrangement and the filter arrangement are accommodated in a common housing.
3. The filter-drier arrangement according to claim 1 wherein the short-circuiting path extends adjacently to at least one surface of the drier arrangement.
4. The filter-drier arrangement according to claim 1, wherein the drier arrangement is made to be cylindrical.
5. The filter-drier arrangement according to claim 1, wherein the drier arrangement has a through, central recess.
6. The filter-drier arrangement according to claim 5, wherein the cross-section of the central recess tapers, particularly conically.
7. The filter-drier arrangement according to claim 1, wherein the drier arrangement comprises a self-supporting drying material.
8. The filter-drier arrangement according to claim 1, wherein the filter arrangement is located in the area of the outlet connection and touches particularly the drier arrangement.
9. The filter-drier arrangement according to claim 1, wherein the filter arrangement is made as a resilient membrane, and particularly made of polyester.
10. The filter-drier arrangement according to claim 1, wherein adjacent to the filter arrangement the housing of the filter arrangement has a hollow in the downstream direction.
11. The filter-drier arrangement according to claim 1, wherein size, fixing and resiliency of the filter arrangement have been chosen so that a flow of refrigerant through the filter arrangement will cause the filter arrangement to be resiliently deformed in such a manner that at least one cavity is formed between the filter arrangement and an adjacent supporting surface.
12. A refrigerant circuit with at least one drier arrangement and at least one filter arrangement for the refrigerant, wherein at least a part of the refrigerant flows in parallel through the filter arrangement and the drier arrangement.
13. The refrigerant circuit according to claim 12, wherein at least one feature according to claim 1.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A composition comprising:
a polyanion selected from the group consisting of heparin, heparan sulphate, and a polyanion equivalent to heparin or heparan sulphate selected from the group consisting of dextran sulphate, curdian sulphate, 2-naphthalene sulphonate polymer, pentosan polysulphate and resobene, said polyanion having a degree of polymerization dp of 10 to 24, and
a CD4 peptide of according to formula (I):
(Cys or TPA)-P1-Cys-P2-Cys-P3-Cys-(Ala or Gln)-(Gly or (D)Asp or Ser)-(Ser or His or Asn)-XaaJ-Cys-(Thr or Ala)-Cys-Xaak-NH2\u2003\u2003(I)
wherein TPA represents thiopropionic acid, XaaJ represents \u03b2-naphthylalanine or biphenylalanine, Xaak represents Gly, Val or Ile, P1 represents 3 to 6 amino acids, P2 represents 2 to 4 amino acids and P3 represents 6 to 10 amino acids, the amino acids in P1, P2 and P3 being natural or unnatural, identical or different, and P1, P2 and P3 optionally having a common sequence, said CD4 peptide sequence according to formula (I) having a \u03b2-hairpin conformation wherein the \u03b2-turn comprises the amino acid residues (Ala or Gln)-(Gly or (D)Asp or Ser)-(Ser or His or Asn)-XaaJ.
2. The composition according to claim 1, wherein said polyanion has a degree of polymerization dp of 12 to 20.
3. The composition according to claim 1, wherein said polyanion has a degree of polymerization dp of 15 to 17.
4. The composition according to claim 1, wherein the CD4 peptide according to formula (I) is selected from group consisting of SEQ ID NO:5, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13 and SEQ ID NO:14.
5. The composition according to claim 1, wherein the composition comprises 1 to 10 mol of polyanion per 0.5 to 1.5 mol of the CD4 peptide according to formula (I).
6. The composition according to claim 1, wherein the composition comprises 5 mol of polyanion per mole of the CD4 peptide according to formula (I).
7. An anti-HIV composition comprising the composition according to claim 1.